Tag Archive for: Healthcare

Sector updates in June

  Investment firms Samsung launched ‘Samsung Life Science Fund 3’, a $145 million fund to invest in global biotech companies and support strategic collaborations THENA Capital closed its inaugural Fund I, at £45 million, to back UK medtech startups, anchored by the British Business Bank Investors Trent Munro appointed Venture Partner at Brandon Capital Karolina […]

Hot Topic: Who do you trust – man or machine?

Last month I went to Copenhagen for the LSX Nordic conference, which was great. The metro ride from the airport to the city centre in a driverless train was a novelty for me, as tube trains on the London Underground all have drivers. I thought no more about it. What if, though, the aeroplane in […]

Hot Topic: Lilly’s big investment into vaccines

 ARE vaccines coming in from the cold? That’s the question this week after Eli Lilly splashed out almost $4 billion on three vaccine biotechs, two of which are in the early stage of clinical development. All are developing jabs for or related to infectious diseases. Why’s this a big deal? Because everyone knows that […]

Weekly Roundup: Exciting clinical stage updates and your LSX Nordic Congress summary

Progress for our clients in the clinic this week, with Mestag Therapeutics dosing the first patient in their STARLYS clinical trial and STORM Therapeutics to present data on its dose escalation study at ASCO later this month. More good news, as Hansa Biopharma entered a multi-million-Euro licensing agreement with SERB S.A. Bring on the bank […]

© Optimum Strategic Communications.